Mice that received AAV8.CII prophylaxis had an approximate 50% reduction in the OD of pro-inflammatory IFNγ and a concomitant 2.5-fold increase in IL-10 level when compared to arthritis controls. This evidence concerns the gene IL10 and arthritic joint disease.